GlassScriptPhysician profile
Michael R Wolff
NPI 1902975428
$4,898.23
in general payments reported to CMS, 2019-2025
32 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $795 · 2020: $591 · 2021: $971 · 2022: $1,218 · 2023: $1,308 · 2024: $14.40.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,222.57 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,058.49 | 2019-2023 | Erleada, Abiraterone Acetate |
| Endo Pharmaceuticals INC. | $626.78 | 2019-2023 | Xiaflex, Aveed |
| Antares Pharma, INC. | $527.52 | 2019-2023 | Nocdurna, Tlando, Xyosted |
| Neotract INC. | $410.65 | 2019-2020 | |
| C. R. Bard, INC. & Subsidiaries | $355.90 | 2023-2024 | Bard Urinary Drainage Bag |
| Myovant Sciences INC. | $247.72 | 2021-2022 | |
| Zyla Life Sciences, INC. | $225.84 | 2019-2020 | |
| Clarus Therapeutics INC. | $191.11 | 2021 | |
| Pfizer INC. | $190.90 | 2019-2023 | |
| Sumitomo Pharma America, INC. | $169.65 | 2023 | Orgovyx, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $152.90 | 2022-2023 | |
| Hollister Incorporated | $84.73 | 2022-2023 | Vapro, Onli, Infyna Chic |
| Agiliti Surgical, INC. | $79.62 | 2022 | |
| Acerus Pharmaceuticals Corporation | $79.09 | 2020-2022 | |
| Mission Pharmacal Company | $70.08 | 2022-2023 | Uribel |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Halozyme INC | $51.89 | 2023 | |
| Urovant Sciences INC | $50.28 | 2022 | |
| Allergan, INC. | $43.26 | 2019-2021 | |
| Boston Scientific Corporation | $42.24 | 2019-2021 | |
| Teleflex LLC | $34.24 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $29.05 | 2022 | |
| Tolmar, INC. | $27.18 | 2023 | |
| Dendreon Pharmaceuticals LLC | $23.60 | 2019 | |
| Laborie Medical Technologies Corp. | $21.51 | 2022 | |
| Collegium Pharmaceutical, INC. | $16.78 | 2021 | |
| Blue Earth Diagnostics | $16.27 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.76 | 2022 | |
| Cure Medical LLC | $14.41 | 2019 | |
| Medtronic, INC. | $13.01 | 2021 | |
| Medtronic USA, INC. | $12.44 | 2020 | |
| Angiodynamics, INC. | $12.04 | 2021 | |
| Astellas Pharma US INC | $3.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.